Published in Cancer Weekly, November 8th, 2005
The study shows that over an estimated 10-year period, men who have an annual prostate specific antigen (PSA) test will have a 3.6% chance of dying from the disease, compared to 11.3% in the general population. Patients who have the test are more likely to be diagnosed with prostate cancer that is curable in the vast majority of cases, as opposed to aggressive cancers...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.